The impact of biological features for a better prediction of posttransplant hepatocellular cancer recurrence.

Lai, Quirino;Lesari, Samuele;Lerut, Jan
(2022) Current Opinion in Organ Transplantation — Vol. 27, n° 4, p. 305-311 (2022)

Files

2022_Lai_Curr_Opin_Organ_Transplant_Ab.pdf
  • Open Access
  • Adobe PDF
  • 372.39 KB

Details

Authors
  • Lai, Quirino
    Author
  • Lesari, SamueleUCLouvain
    Author
  • Lerut, Janorcid-logoUCLouvain
    Author
Abstract
PURPOSE OF REVIEW: Morphological criteria (i.e., Milan Criteria) have been considered for a long time to be the best tool for selecting patients with hepatocellular cancer (HCC) waiting for liver transplantation (LT). In the last ten years, a refinement of the selection criteria has been observed, with the introduction of biological tumor characteristics enabling to enlarge the number of potential transplant candidates and to select LT candidates with a lower risk of posttransplant recurrence. RECENT FINDINGS: Several biological tumor aspects have been explored and validated in international cohorts to expand the ability to predict patients at high risk for recurrence. Alpha-fetoprotein, radiological response to locoregional treatments, and other more recently proposed markers have been principally explored. Moreover, more complex statistical approaches (i.e., deep learning) have been advocated to explore the nonlinear intercorrelations between the investigated features. SUMMARY: The addition of biological aspects to morphology has improved the ability to discriminate among high- and low-risk patients for recurrence. New prognostic algorithms based on the more sophisticated artificial intelligence approach are further improving the capability to select LT candidates with HCC.
Affiliations

Citations

Lai, Q., Lesari, S., & Lerut, J. (2022). The impact of biological features for a better prediction of posttransplant hepatocellular cancer recurrence. Current Opinion in Organ Transplantation, 27(4), 305-311. https://doi.org/10.1097/MOT.0000000000000955 (Original work published 2022)